| Income Statement | 2025-09-30 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Net operating revenues | - | 5,122 | 5,103 | |
| Net operating revenues | 5,289 | 4 | 5 | |
| Equity in earnings of unconsolidated affiliates | 64 | 62 | 61 | |
| Litigation and investigation costs | - | -9 | -5 | |
| Salaries, wages and benefits | 2,204 | 2,218 | 2,168 | |
| Supplies | 931 | 881 | 908 | |
| Other operating expenses, net | 1,119 | 1,111 | 1,148 | |
| Depreciation and amortization | 218 | 209 | 208 | |
| Impairment and restructuring charges, and acquisition-related costs | 23 | 19 | 29 | |
| Litigation and investigation costs (benefit) | -11 | - | - | |
| Net gains on sales, consolidation and deconsolidation of facilities | 20 | 348 | 58 | |
| Operating income | 889 | 1,089 | 761 | |
| Interest expense | 206 | 202 | 203 | |
| Other non-operating income, net | 29 | 35 | 29 | |
| Loss from early extinguishment of debt | 0 | - | 0 | |
| Income before income taxes | 712 | 922 | 587 | |
| Tax benefit attributable to noncontrolling interests | - | - | 46 | |
| Other items | - | - | 3 | |
| Tax expense at statutory federal rate of 21% | - | - | 123 | |
| Nondeductible goodwill | - | - | 2 | |
| Stock-based compensation tax benefit | - | - | -1 | |
| State income taxes, net of federal income tax benefit | - | - | 22 | |
| Changes in valuation allowance | - | - | 7 | |
| Income tax expense | 133 | 241 | 110 | |
| Net income | 579 | 681 | 477 | |
| Less net income available to noncontrolling interests | 237 | 209 | 218 | |
| Net income available to tenet healthcare corporation common shareholders | 342 | 472 | 259 | |
| Basic (in shares) | 87,951,000 | 95,665,000 | 97,267,000 | |
| Basic earnings per share ((in dollars per share) | 3.89 | 4.93 | 2.66 | |
| Diluted (in shares) | 88,610,000 | 96,652,000 | 98,444,000 | |
| Diluted earnings per share (in dollars per share) | 3.86 | 4.89 | 2.64 | |
TENET HEALTHCARE CORP (THC)
TENET HEALTHCARE CORP (THC)